HempNewsBreaks Archive - Page 241 of 262

TuesdayOct 17, 2017 12:11 pm

HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter

PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August. This total is equivalent to 60 percent of the company’s revenues for the first six months of the year, leading PotNetwork to forecast another record-breaking quarter. This projection is further strengthened by Diamond CBD’s early reports for September sales, which the company notes “exceeded expectations” in spite of service interruptions stemming from Hurricane Irma. “We continue to be excited by our continued escalating revenues month-after-month,” Maria Gomez, regional vice president of sales for…

TuesdayOct 17, 2017 10:29 am

HempNewsBreaks – SinglePoint, Inc. (SING) Announces Acquisition of Profitable Denver-Based Company

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its acquisition of a 51 percent stake in JAG, a Denver-based group. Through July 2017, the newly-acquired JAG recorded $600,000 in revenue with gross margins of roughly 26 percent. These results followed full-year 2016 revenue of $700,000 and continued to build on the company’s trend of consistently achieving year-over-year growth since commencing operations in 2014. “We are very excited for this opportunity as it dramatically increases SinglePoint revenues and profitability,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “We look forward to continuing investing in and growing SinglePoint's…

TuesdayOct 17, 2017 10:02 am

HempNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Provides Update on INM-405 Development

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment of pain. Notably, results from the company’s studies suggest that peripheral application of certain cannabinoid compounds, alone or in combination, is effective in the treatment of craniofacial muscle pain disorders, without any observed CNS side effects. InMed suggests that this lack of side effects may position cannabinoid-based compounds as more desirable treatment options than existing systemic pain-relief administration. News of these findings follows the company’s recent filing of a provisional patent application in the United States…

TuesdayOct 17, 2017 9:32 am

HempNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Names Paul Lucas as New Board Chair

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced its appointment of Paul Lucas as its new independent chair following founder Ken Clement’s decision to step down from the position. Clement will continue to serve as a member of the company’s board of directors. “Ken’s visionary leadership has given ABcann a great foundation to build upon and we appreciate his years of dedicated service and contributions,” Paul Lucas stated in the news release. “Having him maintain his position on the Board will help the Company maintain continuity of leadership and historical knowledge. I am thrilled to take on the…

MondayOct 16, 2017 9:13 am

HempNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Makes Successful Showing at 2017 Southwest Cannabis Conference and Expo

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona. “Attending this event was an excellent opportunity for us to share the vast array of technology and business-related solutions MoneyTrac has to offer to the many new and existing businesses in cannabis,” James Hancock, CEO of MoneyTrac, stated in the news release. “In having had the chance to speak with several different owners of these businesses, it…

FridayOct 13, 2017 11:34 am

HempNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

FridayOct 13, 2017 11:16 am

HempNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

ThursdayOct 12, 2017 2:27 pm

HempNewsBreaks – Why Skinvisible, Inc. (SKVI) is Worth Watching in a $65B Market

Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is an R&D company offering its patented Invisicare® technology, which can be used to revitalize or create new medical or skincare products, thus enabling companies that license Skinvisible’s formulations to sell their own patented products and ward off generic rivals. A high-performance topical and transdermal delivery system, Invisicare enhances the delivery of drugs and other ingredients to and through the skin utilizing Skinvisible’s innovative formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. An article discussing this reads: “A prescription dermatology product…

ThursdayOct 12, 2017 9:30 am

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids

Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology. This technology is already being applied to the use of non-psychoactive cannabinoids, yielding a high-absorption hemp oil formula that is a source of omega and fatty acids, and patents are pending for tetrahydrocannabinol (THC) and other psychoactive cannabinoids along with nicotine and nonsteroidal anti-inflammatory drugs. An article discussing this reads: “The patent awarded to LXRP for the delivery of all non-psychoactive…

ThursdayOct 12, 2017 9:30 am

HempNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)

EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs has performed more than 50,000 tests and has evolved from operating one laboratory in Oregon to having nine labs that span California, Oregon, Colorado, Massachusetts and Florida. An article discussing this reads: “EVIO Labs is driving the cannabis testing industry by providing clients nationwide with…

News and publishing service for hemp related companies

Contact us: 512.354.7000

HempNewsBreaks